Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHerald Investment Trust Regulatory News (HRI)

Share Price Information for Herald Investment Trust (HRI)

Share Price is delayed by 15 minutes
Get Live Data
3,160.00    80.00 (2.60%)
Bid:
3,055.00
Ask:
3,070.00
Spread: 15.00 (0.491%)
Market Cap: £603.67m
HRI Live PriceLast checked at - London Stock Exchange

Intraday Herald Investment Trust Share Chart

Response to Saba Statement

9 Jan 2025 12:53

RNS Number : 7924S
Herald Investment Trust PLC
09 January 2025
 

Herald Investment Trust plc

("Herald" or the "Company")

 

LEI: 213800U7G1ROCTJYRR70

 

Response to Saba statement

The Board notes the recent statement from Saba dated 9 January 2025. The Company's investment strategy has delivered strong returns for investors. From first day of dealings on 21 February 1994 to 31 December 2024, the Company has achieved a NAV total return of 2,611.6% for shareholders(1).

The Board notes that Saba is not proposing to offer 99% of the value of today's net asset value. Instead Saba is proposing an exit after "at least a year" during which open-ended time period significant value could be lost from the underlying portfolio in anticipation or consequence of Saba's known selling appetite.

The Board will always listen to shareholder feedback and seek to determine what is in the best interests of all investors. In recent days the Board has engaged with many shareholders and, contrary to what Saba implies, as far as the Board are aware none of these shareholders have expressed a wish for Saba to take over the management of the Company. The Board believes it is imperative that an independent Board reviews these matters acting in the best interests of all shareholders. Accordingly the Board continues to strongly recommend that shareholders VOTE AGAINST the resolutions at the forthcoming general meeting.

Further announcements as required will follow in due course.

Andrew Joy, Chairman said "Herald has delivered strong investment performance. Since the first day of dealings (21 February 1994) the Company has delivered a 27x NAV total return(1). In direct contrast to Saba's promise of the "opportunity for greater long-term returns under a new investment strategy", the Herald Board does not believe that Saba's long term performance track record supports this. The Board reiterates its belief that, since Saba started investing in 2009, it has materially underperformed Herald. Since that date Herald has delivered a NAV total return of over 865%."

Enquiries:

 

Herald Investment Trust plc

via Camarco

Andrew Joy (Chairman)

Camarco (Media enquiries)

+44 (0)20 3757 4980

Billy Clegg / Ben Woodford / Eddie Livingstone-Learmonth

Herald@camarco.co.uk

Singer Capital Markets (Corporate Broker)

+44 (0)20 7496 3000

Alan Geeves / Sam Greatrex / James Waterlow / William Gumpel (Sales)

James Maxwell / Alaina Wong (Investment Banking)

J.P. Morgan Cazenove (Financial Adviser)

+44 (0)20 3493 8000

William Simmonds / Rupert Budge

NSM Funds (UK) Limited (Company Secretary)

HIT@nsm.group

Brian Smith / Shilla Pindoria

 

Important information

 

(1) Excluding warrant returns.

 

Past performance is not a reliable indicator of future results. All figures contained in this announcement are unaudited.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPBDGDBBUGDGUC
Date   Source Headline
21st Oct 20244:40 pmRNSHolding(s) in Company
21st Oct 202411:54 amRNSNet Asset Value(s)
18th Oct 202412:34 pmRNSNet Asset Value(s)
17th Oct 202411:25 amRNSNet Asset Value(s)
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 202411:26 amRNSNet Asset Value(s)
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20244:15 pmRNSStatistics and Performance Report
15th Oct 202411:59 amRNSNet Asset Value(s)
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20242:05 pmRNSHolding(s) in Company
14th Oct 202412:36 pmRNSNet Asset Value(s)
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 202411:46 amRNSNet Asset Value(s)
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20244:39 pmRNSHolding(s) in Company
10th Oct 202411:34 amRNSNet Asset Value(s)
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 202411:50 amRNSNet Asset Value(s)
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20244:06 pmRNSHolding(s) in Company
8th Oct 202412:27 pmRNSNet Asset Value(s)
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 202411:32 amRNSNet Asset Value(s)
4th Oct 202411:23 amRNSNet Asset Value(s)
3rd Oct 202411:49 amRNSNet Asset Value(s)
2nd Oct 20243:47 pmRNSHolding(s) in Company
2nd Oct 202411:45 amRNSNet Asset Value(s)
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20243:47 pmRNSNet Asset Value(s)
1st Oct 20249:00 amRNSCompany Secretary Change
1st Oct 20247:01 amRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 202412:14 pmRNSNet Asset Value(s)
30th Sep 202410:46 amRNSHolding(s) in Company
30th Sep 20247:00 amRNSTransaction in Own Shares
27th Sep 202412:07 pmRNSNet Asset Value(s)
27th Sep 20247:00 amRNSTransaction in Own Shares
26th Sep 202411:52 amRNSNet Asset Value(s)
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 202411:30 amRNSNet Asset Value(s)
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20241:54 pmRNSNet Asset Value(s)
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 202411:44 amRNSNet Asset Value(s)
19th Sep 202411:24 amRNSNet Asset Value(s)
18th Sep 202411:29 amRNSNet Asset Value(s)
17th Sep 20245:26 pmRNSStatistics and Performance Report
17th Sep 202411:57 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.